Growth hotspot Chalice Medical is expanding into the U S market with ECLS solutions, signaling imminent cross-border sales opportunities for ECMO related products and potentially wider distribution partnerships.

ECMO specialization Core focus on extra-corporeal bypass devices such as oxygenators, cannula and customised tubing packs positions Chalice as a niche supplier to ECMO programs, offering potential for targeted account development with hospitals and surgical centers.

Strategic partnerships As an exclusive distributor for several large international medical device manufacturers, Chalice maintains a channel-ready position that can be leveraged to bundle offerings or co-market complementary devices to enhance sales footprints.

Local capacity A dedicated class-7 cleanroom manufacturing facility and climate-controlled operations in Nottinghamshire indicate reliable supply, quality assurance, and potential for fast lead times to support hospital procurement cycles.

Financial potential With a revenue range of 10 to 25 million USD and a focused product portfolio, Chalice offers a scalable growth path for mid-market customers and distributors seeking ECMO and bypass solutions with margin opportunities.